Visit Foot Blog

No evidence new osteoporosis drugs work better

Posted on December 17, 2007

WASHINGTON (Reuters) December 17th, 2007 - There is no evidence to show that any one group of osteoporosis drugs works better than other drugs designed to fight the bone-thinning disease, U.S. government researchers reported on Monday.But some choices can cause severe side-effects such as blood clots, the Agency for Healthcare Research and Quality, which paid for the study, reported.The team at the Rand Corporation in California compared six drugs in the class known as bisphosphonates Merck & Co Inc s Fosamax, known generically as alendronate; Novartis AG s Zometa or zoledronic acid ...

Original article link


actonel , boniva , fosamax , osteoporosis